FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1236893007: Product containing precisely hydrochlorothiazide 12.5 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5089563011 Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
5089564017 Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besylate) 2.5 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
5089565016 Product containing precisely hydrochlorothiazide 12.5 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Is a Hydrochlorothiazide and levamlodipine only product in oral dose form true Inferred relationship Some
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Plays role Diuretic therapeutic role true Inferred relationship Some
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has precise active ingredient Levamlodipine besilate true Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has BoSS Levamlodipine true Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has precise active ingredient Hydrochlorothiazide true Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has BoSS Hydrochlorothiazide true Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start